Phase I-II study of F17752 in patients with advanced solid tumors

Phase I-II study of F17752 in patients with advanced solid tumors

Hide study title

Status

Status :

Early termination

Type of study

Phase I / II

Min. Age

18

Years old

Max. Age

-

Gender

All

Therapeutic area :

Oncology

Disease :

Solid tumors

Study medication :

F17752

Phase : Phase I / II

Start Date :

01 October 2013

End date :

13 October 2013

Study ID : F17752 GE 101 QO

EudraCT/CTIS number : 2013-003009-24

Results

Public links :

EU Clinical Trials Register